IPP Bureau
Bronchoscopic Thermal Vapor Ablation (BTVA): A new ray of hope for COPD patients
By IPP Bureau - March 31, 2022
Yashoda Hospitals Hyderabad has earned the distinction of becoming the first to introduce BTVA in India
FDI World Dental Federation releases statement on sustainable oral healthcare
By IPP Bureau - March 31, 2022
It paves the way for an industry Code of Good Practice
HealthQuad raises US $ 162 million in second fund
By IPP Bureau - March 31, 2022
The fund has already invested in seven companies including Medikabazaar, THB, Impact Guru, Stanplus, Ekincare, Qure.ai and HealthifyMe
BioVaxys expands cancer vaccine platform
By IPP Bureau - March 31, 2022
BVX-0922 to target colorectal cancer under investigator-sponsored IND
CerroZone reduces airborne Covid-19 Delta variant by 99.998% in 1.2 seconds
By IPP Bureau - March 31, 2022
Air purification system achieves Intertek zero ozone certification
Symbiance announces the launch of SimpleStats to help pharma and biotech industries
By IPP Bureau - March 31, 2022
It is an application to automate statistical analysis and reporting for clinical research.
Researchers discover new model for "Global" DNA repair
By IPP Bureau - March 31, 2022
A major unresolved question in the field, however, is how do this machinery rapidly searches for and finds rare stretches of damage amid the "vast fields" of undamaged DNA
Seventh international meet on Pharma and MedTech from April 25-27 in New Delhi
By IPP Bureau - March 31, 2022
The event will have a mix of policymakers, national and international leaders from the pharma industry, MSME, innovators, academic and research fraternity
Cipla Medpro South Africa partners with mAbxience for affordable cancer drugs
By IPP Bureau - March 31, 2022
The mAbxience partnership will enable Cipla to continue its ethos of ensuring equitable access to affordable, life-saving medication
National Health Authority releases consultation paper on Drug Registry
By IPP Bureau - March 31, 2022
The Drug Registry intends to create a nationally recognized source of information on various systems of medicine in the country
Phablecare acquires Fused Training, a startup combating Type-1 Diabetes
By IPP Bureau - March 31, 2022
Phablecare closed this acquisition for an undisclosed sum, betting on the start-up's holistic approach to Type 1 Diabetes management
USFDA approves Edwards Mitris Resilia valve
By IPP Bureau - March 31, 2022
The valve has a saddle-shaped sewing cuff that mimics the asymmetric shape of the native mitral valve
SRV Hospitals and Lokmanya Hospital launch centre for robotic orthopaedics
By IPP Bureau - March 30, 2022
The SRV LHPL centre of excellence in robotic orthopaedics will be helmed by joint replacement surgeon, Dr Narendra Vaidya
Govt clears 49 applicants for PLI in Bulk Drugs
By IPP Bureau - March 30, 2022
The selected 49 applications are from 33 companies. Out of these 33 companies, 13 are Micro, Small and Medium Enterprises (MSMEs) besides some newly incorporated entities
Ondexxya approved in Japan for reversal of acute major bleeds in patients on Factor Xa inhibitors
By IPP Bureau - March 30, 2022
Ondexxya is the first approved reversal agent specifically for Factor Xa inhibitors, providing a major advance in the treatment of patients hospitalised with life-threatening bleeding
